CRSP
$49.25-4.41%
CRSP financial statements
The full income statement, balance sheet, and cash-flow statement for CRISPR Therapeutics AG (CRSP), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 85.2M2024-09 85.4M2024-12 85.8M2025-03 86.4M2025-06 91.0M2025-09 95.3M2025-12 96.0M2026-03 96.4M2026-06 96.7M+13.5% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
As-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 3.51M-90.6% | 37.3M-89.9% | 371M+30885.5% | 1.20M-99.9% | 915M+127154.9% | |
| 668M+32.6% | 504M-15.1% | 594M-12.0% | 674M+24.6% | 541M+52.5% | ||
| Research & development | 285M-8.2% | 310M-19.9% | 387M-16.1% | 462M+35.6% | 341M+53.8% | |
| Selling, general & administrative | 73.5M+0.8% | 73.0M-4.2% | 76.2M-25.7% | 102M+2.8% | 99.7M+16.3% | |
| General & administrative | 73.5M+0.8% | 73.0M-4.2% | 76.2M-25.7% | 102M+2.8% | 99.7M+16.3% | |
| Operating income | -665M-42.4% | -467M-109.7% | -223M+66.9% | -673M-280.2% | 374M+205.4% | |
| Interest & investment income | — | 104M+36.5% | 76.4M+227.9% | 23.3M | — | |
| Other non-operating income | 86.6M-16.6% | 104M+44.7% | 71.8M+216.9% | 22.7M+277.5% | 6.00M-5.9% | |
| Gain (loss) on equity securities | — | 4.10M | — | — | — | |
| Pre-tax income | -578M-59.4% | -363M-140.6% | -151M+76.8% | -651M-271.4% | 380M+209.0% | |
| Income tax | 3.63M+1.3% | 3.59M+24.2% | 2.89M+988.6% | -325K-117.4% | 1.87M+131.1% | |
| Net income | -582M-58.8% | -366M-138.4% | -154M+76.4% | -650M-272.2% | 378M+208.3% | |
| -$6.47-49.1% | -$4.34-123.7% | -$1.94+76.8% | -$8.36-277.9% | $4.70+188.8% | ||
| EPS (basic) | -$6.47-49.1% | -$4.34-123.7% | -$1.94+76.8% | -$8.36-268.2% | $4.97+194.0% | |
| Weighted-avg shares (basic) | 89.9M+6.6% | 84.4M+6.5% | 79.2M+1.9% | 77.7M+2.4% | 75.9M+15.2% | |
| Weighted-avg shares (diluted) | 89.9M+6.6% | 84.4M+6.5% | 79.2M+1.9% | 77.7M-3.3% | 80.4M+21.9% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 1.99B+2.5% | 1.94B+1.5% | 1.91B+3.0% | 1.85B-23.3% | 2.42B+40.8% | ||
| Cash & equivalents | 348M+16.5% | 298M-23.4% | 389M+83.8% | 212M-77.0% | 923M-21.0% | |
| Short-term investments | 1.63B+1.4% | 1.61B+23.1% | 1.30B-18.7% | 1.60B+10.1% | 1.46B+179.1% | |
| Accounts receivable | 0.00-100.0% | 25.0M-87.5% | 200M | 0.00-100.0% | 305K+111.8% | |
| Prepaid expenses | 9.84M+18.5% | 8.31M-42.3% | 14.4M-61.8% | 37.7M-1.0% | 38.1M+45.7% | |
| 2.27B+1.0% | 2.24B+0.6% | 2.23B-0.6% | 2.24B-18.5% | 2.75B+50.5% | ||
| Property, plant & equipment | 116M-13.6% | 134M-11.7% | 152M-7.1% | 164M+18.9% | 138M+226.3% | |
| Operating lease right-of-use | 132M-8.2% | 143M-6.8% | 154M-1.9% | 157M-10.1% | 174M+243.0% | |
| Intangible assets | — | 0.00-100.0% | 16.0K-77.5% | 71.0K-43.2% | 125K-30.6% | |
| Long-term investments | 0.00 | 0.00-100.0% | 1.97M-96.3% | 53.1M | 0.00 | |
| Other non-current assets | 24.4M+53.9% | 15.8M+701.5% | 1.98M-57.4% | 4.64M-12.3% | 5.29M+309.2% | |
| 149M+69.9% | 87.8M-19.3% | 109M-10.2% | 121M+1.0% | 120M+27.2% | ||
| Accounts payable | 11.1M-24.3% | 14.7M-61.4% | 38.1M+39.1% | 27.4M+85.1% | 14.8M+62.9% | |
| Accrued liabilities | 89.4M+117.7% | 41.1M-9.4% | 45.3M-41.6% | 77.7M-14.6% | 91.0M+69.2% | |
| Deferred revenue | 15.8M+310.2% | 3.85M-6.3% | 4.11M | 0.00-100.0% | 1.01M-56.8% | |
| Current lease liability | 18.6M+7.5% | 17.3M+10.6% | 15.6M-1.4% | 15.8M+30.3% | 12.2M+7.0% | |
| Other current liabilities | 13.1M+25.9% | 10.4M+102.6% | 5.14M+25605.0% | 20.0K-88.3% | 171K-97.6% | |
| 343M+10.8% | 310M-10.6% | 347M-5.7% | 368M+4.3% | 352M+115.2% | ||
| Long-term debt | 0.00 | — | — | — | — | |
| Deferred revenue (non-current) | 0.00-100.0% | 12.3M-12.1% | 14.0M+13.7% | 12.3M+0.0% | 12.3M+4.6% | |
| Non-current lease liability | 188M-8.8% | 206M-7.4% | 223M-2.3% | 228M+7.2% | 213M+325.2% | |
| Operating lease liability (total) | 207M-7.6% | 224M-6.3% | 239M-2.2% | 244M+8.4% | 225M+266.3% | |
| Other non-current liabilities | 6.14M+78.3% | 3.44M+259.5% | 958K-84.0% | 5.97M-18.7% | 7.34M-3.8% | |
| 1.92B-0.5% | 1.93B+2.6% | 1.88B+0.4% | 1.88B-21.8% | 2.40B+44.2% | ||
| Common stock | 3.09M+14.4% | 2.70M+8.0% | 2.50M+2.3% | 2.44M+2.1% | 2.39M+5.0% | |
| Additional paid-in capital | 3.86B+17.2% | 3.29B+14.4% | 2.88B+5.2% | 2.73B+5.3% | 2.60B+16.2% | |
| Retained earnings | -1.95B-42.6% | -1.37B-36.6% | -1000M-18.2% | -846M-331.9% | -196M+65.8% | |
| Treasury stock | 60.0K-3.2% | 62.0K+0.0% | 62.0K-1.6% | 63.0K+0.0% | 63.0K+0.0% | |
| Accumulated other comprehensive income | 4.82M+162.0% | 1.84M-3.8% | 1.91M+112.2% | -15.6M-208.8% | -5.07M-6004.8% | |
| Total liabilities & equity | 2.27B+1.0% | 2.24B+0.6% | 2.23B-0.6% | 2.24B-18.5% | 2.75B+50.5% | |
| Common shares issued | 96.0M+11.8% | 85.9M+7.1% | 80.2M+1.9% | 78.7M+2.0% | 77.2M+4.1% | |
| Common shares outstanding | 95.9M+11.8% | 85.7M+7.1% | 80.0M+2.0% | 78.5M+2.0% | 77.0M+4.2% | |
| Shares outstanding (cover) | 96.0M+11.9% | 85.8M+6.8% | 80.3M+2.1% | 78.6M+2.0% | 77.1M+2.2% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| -345M-141.7% | -143M+45.2% | -260M+47.5% | -496M-192.0% | 539M+326.1% | ||
| Depreciation & amortization | 19.5M+1.1% | 19.3M-2.9% | 19.8M-17.9% | 24.2M+34.6% | 18.0M+95.5% | |
| Share-based compensation | 72.5M-16.3% | 86.6M+6.8% | 81.0M-17.3% | 97.9M-4.3% | 102M+55.1% | |
| Deferred income taxes | 915K+289.0% | -484K-14.2% | -424K+58.0% | -1.01M-157.8% | 1.75M+327.4% | |
| Change in receivables | -25.0M+85.7% | -175M-187.5% | 200M+65673.8% | -305K-289.4% | 161K+257.8% | |
| -31.8M+88.7% | -280M-174.9% | 375M+244.8% | -259M+75.0% | -1.04B-91.3% | ||
| Capital expenditure | 914K-51.9% | 1.90M-79.9% | 9.47M-74.5% | 37.2M-54.5% | 81.7M+345.1% | |
| Free cash flow | -346M-139.1% | -145M+46.4% | -270M+49.4% | -533M-216.5% | 457M+278.1% | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 426M+28.3% | 332M+429.8% | 62.7M+62.4% | 38.6M-84.6% | 251M-75.3% | ||
| Long-term debt issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock issued | 398M+32.4% | 301M+819.0% | 32.7M+3273.3% | 970K-99.5% | 213M-78.3% | |
| Common stock repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net change in cash | 49.3M+154.0% | -91.3M-151.6% | 177M+124.7% | -716M-191.6% | -246M-203.7% | |
| Income taxes paid | 2.98M | — | — | — | — | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 5.03B+49.1% | 3.38B-32.1% | 4.97B+56.2% | 3.18B-45.5% | 5.84B-49.4% | |
| P/E | — | — | — | — | 15.5× | |
| P/S | 1434.0×+1485.0% | 90.5×+209.3% | 29.2×-87.1% | 225.9×+3438.5% | 6.4×-100.0% | |
| P/B | 2.6×+49.9% | 1.7×-39.3% | 2.9×+76.7% | 1.6×-33.1% | 2.4×-64.9% | |
| P/FCF | — | — | — | — | 12.8× | |
| Earnings yield | — | — | — | — | 6.5% | |
| FCF yield | — | — | — | — | 7.8% | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: CRSP’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all CRSP filings on SEC EDGAR → Not investment advice.